Skip to content
ClinCalc Pro
Menu
Heparin Reversal / Cardiac Surgery

Protamine Sulphate (Heparin Reversal)

Brand names: Protamine Sulphate 1%

Used in: Venous Thromboembolism (DVT & PE)

Protamine sulphate is an intravenous antidote used to neutralise the anticoagulant effect of heparin, most often to reverse unfractionated heparin after cardiopulmonary bypass or other procedures.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Protamine is a strongly basic protein that binds electrostatically to acidic heparin to form an inactive stable complex, abolishing heparin's antithrombin-mediated anticoagulant activity; it only partially reverses low-molecular-weight heparins.

Prescribing in practice

  • Inject slowly because rapid administration can cause severe hypotension, bradycardia, anaphylactoid reactions and pulmonary hypertension; have resuscitation facilities available.
  • Patients exposed to protamine-containing insulins, those with fish allergy and men who are infertile or have had a vasectomy are at higher risk of hypersensitivity.
  • Excessive protamine has its own anticoagulant effect, and rebound anticoagulation (heparin rebound) can occur after cardiac surgery; titrate the dose to the heparin to be neutralised.

Monitoring

Monitor blood pressure, heart rate and coagulation parameters such as the activated clotting time or APTT during and after administration to confirm reversal and detect rebound.

Counselling the patient

  • Inform the team if you have a fish allergy, take a protamine-containing insulin or have had a vasectomy.
  • Report any breathlessness, flushing or feeling faint during the injection.

Evidence & guidelines

Protamine reversal of heparin is standard practice in cardiac surgery and established prescribing references, with MHRA-recognised risks of serious cardiovascular and hypersensitivity reactions on rapid administration.

Reference: Cardiothoracic Anaesthesia Society Guidelines; AAGBI Guidelines; SPC Protamine Sulphate 1%; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.